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Factor Receptor
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Sulochanadevi Baskaran5 and Raymond L. Konger1,6
UVB radiation (UVB) is a known inducer of many biological changes in human skin, and triggers the production
of glycerophosphocholines that act as platelet-activating factor (PAF) agonists. To gain a better insight into the
role of the epidermal PAF receptor (PAF-R) in UVB-mediated gene expression, Affymetrix oligonucleotide
microarrays were used to compare mRNA expression in the PAF-R-negative epithelial cell line KB-expressing
PAF-Rs (KBP) with that in KB cells transduced with a vector control (KBM). Total RNA was isolated from KB cells
1 hour after treatment with a PAF-R agonist or UVB irradiation. Treatment of KBP with PAF agonist resulted in
altered expression of 220 genes, including cytokines and growth factors. UVB irradiation of KB cells resulted in
an increased expression of genes in both cell types. A panel of genes including cytokines CCL20 (MIP3a) and
tumor necrosis factor-a (TNF-a) were upregulated selectively in KBP cells and are also selectively upregulated in
response to PAF agonist. Consistent with these in vitro findings, UVB irradiation resulted in increased levels of
epidermal CCL20 and TNF-a mRNA in wild-type over PAF-R-deficient mice in vivo. These studies provide
evidence that the epidermal PAF-R can modulate UVB-mediated early gene expression.
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INTRODUCTION
UVB radiation (UVB; 290–320 nm) is the most important
environmental carcinogen, and skin is the major target. In
addition to its ability to damage DNA, UVB can modify
epithelial gene expression. The known UV response consists
of the rapid activation of numerous genes with reparative,
protective, or apoptotic effects, as well as genes encoding
cytokines and other signaling molecules with potent im-
munomodulatory effects (Sesto et al., 2002; Pisarchik et al.,
2004; Enk et al., 2006).
Accumulating evidence suggests platelet-activating factor
(PAF; 1-alkyl-2-acetyl glycerophosphocholine)-mediated
pathways are involved in cutaneous inflammation and
epithelial cell stress responses (reviewed by Prescott et al.,
2000). Epithelial cells synthesize PAF and related 1-acyl-PAF-
like species in response to various stimuli including
ionophores, growth factors, PAF agonists, the pro-oxidative
stressor, tert-butyl hydroperoxide, UV light irradiation, or
acute thermal damage (Travers et al., 1996; Travers, 1999;
Alappatt et al., 2000; Walterscheid et al., 2002; Marathe
et al., 2005). Although PAF can be metabolized to other
biologically active lipids, the majority of PAF effects appear to
be mediated by interaction with the PAF receptor (PAF-R), a
G-protein-coupled receptor (reviewed by Ishii et al., 2002). In
addition to producing PAF, keratinocytes and many carcinoma
cell lines also express the PAF-R (Travers et al., 1995).
Activation of the epidermal PAF-R leads to the production
and release of PAF, IL-6, IL-8, IL-10, tumor necrosis factor-a
(TNF-a), and eicosanoids (Travers et al., 1996; Pei et al., 1998;
Dy et al., 1999; Walterscheid et al., 2002).
PAF can be synthesized through a tightly coupled
enzymatic pathway involving phospholipase A2 and acetyl-
transferase; in addition, PAF and PAF-like lipids can be
produced via direct free radical-mediated cleavage of
glycerophosphocholines containing unsaturated fatty acids
(e.g., arachidonate) at the sn-2 position (Marathe et al., 2005).
Recent studies have suggested that the PAF-R is a target for
UVB in part through this non-enzymatic pathway of PAF
agonist formation. For example, expression of the PAF-R in
the PAF-R-negative human epithelial cell line KB results in an
augmentation of the production of cytokines IL-8 and TNF-a
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in response to UVB in a process inhibited by antioxidants
(Dy et al., 1999; Countryman et al., 2000). In addition,
PAF-R-expressing KB cells are more susceptible to UVB-
mediated apoptosis (Barber et al., 1998). Overexpression of
the PAF-R in primary cultures of human keratinocytes
also results in an augmentation of UVB-mediated cytotoxicity
both in vitro and in vivo when PAF-R overexpressing
human keratinocytes are xenografted onto immuno-
deficient mice (Marathe et al., 2005). Studies by Ullrich
and colleagues suggest that UVB-generated PAF and PAF-like
lipids are important for UVB-mediated immunosuppression
(Walterscheid et al., 2002).
The objective of the present studies was to assess the role
of the PAF-R in UVB-mediated early gene expression. To that
end, we used Affymetrix oligonucleotide arrays to examine
the early expression of over 22,000 transcripts in KB cells
with and without the PAF-R. To assess the role of the PAF-R in
cytokine production in vivo, gene expression in wild-type
and PAF-R-deficient mice was evaluated following UVB
treatment. These studies implicate the epidermal PAF-R in
UVB-mediated early gene expression, in particular produc-
tion of the cytokines CCL20 and TNF-a.
RESULTS
The KB PAF-R model system
Because PAF may have both receptor-dependent and -
independent effects (secondary to the formation of biologi-
cally active metabolites), our laboratory has previously
created a cellular model system by transduction of the PAF-
R into a PAF-R-deficient epidermal cell line (Pei et al., 1998).
The human epidermal carcinoma cell line KB does not
express functional PAF-R, unlike normal human keratinocytes
and the human keratinocyte-derived carcinoma cell line
HaCaT (Travers et al., 1995). A PAF-R-positive KB cell line,
KBP, was created by transducing KB cells with a replication-
deficient MSCV2.1 retrovirus containing the human PAF-R
complementary DNA. KB cells were also transduced with the
retroviral empty vector alone to establish a transduction
control cell line, KBM. Expression of the PAF-R protein in the
KBP cells was verified by binding studies using radiolabeled
PAF-R antagonist WEB-2086 (Pei et al., 1998). Calcium
mobilization studies demonstrated that the PAF-R in KBP
cell line was functionally active. Therefore, this in vitro
epidermoid cell system consists of both PAF-R-negative
(KBM) and -positive (KBP) cells.
PAF-R-mediated gene expression in KB cells
Our first studies used Affymetrix genechips to assess early
gene expression in KB cells following carbomoyl-PAF (CPAF)
treatment. KBM and KBP cells were treated with 100 nM of
the metabolically stable PAF-R agonist CPAF and RNA
measured after 1 hour. CPAF treatment resulted in a
statistically significant (Pp0.01) difference in the expression
of many genes; 181 genes were upregulated and 38 genes
were downregulated at least 2-fold (entire list found in Table
S1). A representative list of genes whose expression was
altered is in Table S2. This includes genes involved in
adherens junctions, apoptosis, calcium signaling, cell-cycle
regulation, cytokines, extracellular matrix receptor interac-
tions, Jak-STAT, and mitogen-activated protein kinase signal-
ing pathways. In particular, CPAF treatment induced mRNA
encoding cytokines TNF-a (8.6-fold), IL-6 (11-fold), IL-8
(66-fold), and IL-11 (13-fold). In addition, activation of the
PAF-R strongly induced mRNA encoding chemokines CCL20
(174-fold), CCL2 (23-fold), CXCL1 (31-fold), CXCL2 (25-fold),
and CXCL3 (37-fold). PAF-R activation robustly increased
mRNA encoding growth factors, especially amphiregulin
(21-fold), epiregulin (15-fold), and heparin-binding epidermal
growth factor-like growth factor (DTR; 10-fold). CPAF treat-
ment of KBP cells also induced antiapoptotic genes including
BIRC2 (3.8-fold) and BIRC3 (11-fold), TRAF-1 (4.2-fold) and
MCL1 (3.1-fold). Consistent with the lack of PAF-Rs,
treatment of KBM cells with CPAF did not result in significant
changes in mRNA levels for any genes (fewer genes met the
Pp0.01 criteria then are expected by chance, and only one
reached 2-fold difference).
UVB-mediated early gene expression in KB cells
The next studies examined involvement of the PAF system in
UVB-mediated early gene expression using KB cells. To that
end, KBM and KBP cells were sham-irradiated or irradiated
with 400 J/m2 UVB, and RNA measured after 1 hour. In each
of the cell lines, approximately 190 genes showed differences
in expression (Pp0.01); 49 of these genes were significantly
altered in both KBM and KBP cells (Table S3). Of these genes,
levels of chemokines CXCL1, CXCL2, and CXCL3 are
increased more in KBP cells than in KBM cells. Of note, 20
genes were selectively upregulated in KBP (Table S4).
Cytokines CCL20 and TNF-a were among these genes. The
higher levels of TNF-a in UVB-treated KBP than in KBM cells,
found using Affymetrix genechips fits with our previous
published findings measuring TNF-a mRNA and protein
levels by Northern and Western blotting, respectively (Dy
et al., 1999). Table S5 lists genes selectively upregulated by
UVB treatment in PAF-R-negative KBM cells. These studies
demonstrate significant differences in UVB-mediated gene
expression due to the PAF-R.
UVB-mediated CCL20 protein production in KBP versus KBM
cells
The chemokine CCL20 (MIP3a) is a potent chemoattractant
for CCR6-expressing T cells and immature dendritic cells
(Charbonnier et al., 1999; Le Borgne et al., 2006). Given our
finding that both CPAF and UVB irradiation resulted in
CCL20 mRNA upregulation selectively in KBP cells (Tables
S1 and S3), our next studies examined whether CCL20
protein production behaved in similar manner. As shown in
Figure 1, CCL20 protein levels in unstimulated KBP cells
were significantly increased over KBM cells. Treatment of KB
cells resulted in increased CCL20 protein production
in response to both CPAF and UVB selectively in KBP
cells. However, phorbol 12-myristate 13-acetate treatment
stimulated CCL20 protein production in both KBM and KBP
cells. These findings confirm the microarray studies and
indicate involvement of the PAF-R in UVB-mediated CCL20
production.
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UVB-mediated CCL20 and TNF-a expression in mice
The next studies were designed to evaluate the role of the
PAF-R in UVB-mediated CCL20 and TNF-a expression in
vivo. To that end, the skin of wild-type and PAF-R-deficient
mice were injected intradermally with CPAF or irradiated
with 1,200 J/m2 UVB and skin was harvested 8 hours later
with part snap-frozen in optimal cutting temperature (OCT) to
obtain mRNA and part formalin-fixed for immunohistochem-
istry. RNA was extracted from the tissue and subjected to
real-time reverse transcription (RT)-PCR. Consistent with the
in vitro gene array studies using KB cells, CPAF treatment
induced cytokine mRNA only in wild-type but not PAF-R-
deficient mice (Figure 2). UVB irradiation resulted in
increased levels of CCL20 and TNF-a mRNA in the skin of
both types of mice, yet significantly lower amounts of
cytokine mRNA were measured in PAF-R-deficient mice. In
contrast, mRNA levels of these cytokines produced in
response to topical application of the phorbol 12-myristate
13-acetate (10 mg) did not differ significantly between PAF-R-
positive and -negative mice (data not shown). The next
studies examined TNF-a and CCL20 protein expression in
murine skin in response to CPAF and UVB. As shown in
Figure 3, only minimal protein levels of TNF-a and CCL20
were detected in control skin. Intradermal injection of CPAF
resulted in upregulation of both cytokines in wild-type but
not PAF-R-deficient mice. Consistent with the mRNA
measurements, UVB treatment resulted in enhanced protein
levels of TNF-a and CCL20, which was increased in PAF-R-
expressing mice. These studies indicate that activation of the
endogenous epidermal PAF-R induces TNF-a and CCL20,
and is also involved in UVB-mediated early production of
these cytokines.
DISCUSSION
These studies provide evidence that the epidermal PAF-R can
augment the production of many early genes in response to
UVB. An Affymetrix microarray strategy was used to compare
gene expression in the KB PAF-R model system in response to
the PAF-R agonist CPAF as well as UVB. Activation of the
epidermal PAF-R expressed by KBP cells resulted in the
increased expression of numerous genes as outlined in Table
S1 and S2; no genes were significantly activated by CPAF in
the PAF-R-negative KBM cells, demonstrating that PAF-R was
required for this effect. Chemokines whose expression was
increased in response to PAF-R activation include CCL20, IL-
8, CXCL3, CXCL1, CXCL2, and CCL2. Moreover, mRNA of
cytokines IL-11, TNF-a, and IL-6 was also found to be
increased following PAF-R activation. The variety of chemo-
kines and cytokines upregulated by direct PAF-R activation
suggests that this lipid hormone could play an important
immunomodulatory role in keratinocyte function. Of note,
the ability of the epidermal PAF-R to upregulate growth factor
expression (amphiregulin, epiregulin, and heparin-binding
epidermal growth factor-like growth factor) fits with the
report that the phenotype of the PAF-R overexpressing mouse
includes a hyperproliferative dermatitis (Ishii et al., 1997).
PAF-R activation also resulted in increased expression of
antiapoptotic genes, which fits with our previous findings that
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Figure 1. Effect of PAF-R agonist or UVB irradiation on CCL20 protein levels
in KB cells. KBM and KBP cells were treated with 100 nM of the PAF-R agonist
CPAF, 1 mm of the phorbol ester phorbol 12-myristate 13-acetate, vehicle
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Figure 2. Effect of PAF-R agonist on cytokine mRNA levels in vivo. Skin of
wild-type or PAF-R/ mice was injected with BSA vehicle, 100 ng CPAF, or
irradiated with 1,200 J/m2 UVB. After 8 hours, the skin was harvested and
RNA extracted and subjected to quantitative real-time RT-PCR. The values are
mean7SE mRNA levels of (a) TNF-a and (b) CCL20 normalized to 18S
ribosomal RNA from duplicate samples and are derived from four mice of
each genotype. *Denotes statistically significant (Po0.05 using paired
Student’s t-test) decreases in cytokine mRNA in PAF-R/mice in comparison
with wild-type counterparts.
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activation of the epidermal PAF-R protects against subsequent
apoptosis by TNF family members (Southall et al., 2001). The
lack of genes upregulated in KBM cells in response to CPAF
confirms the utility of this model system.
UVB irradiation of KBM and KBP cells resulted in an
increased expression of numerous genes. As shown in Table
S3, UVB-mediated expression of the majority of genes was
similar in KBP and KBM cells. Although these studies indicate
that the majority of early genes upregulated by UVB do not
involve the PAF system, a group of UVB-regulated early
genes appears to be PAF-responsive. These include CCL20,
CXCL1, CXCL2, CXCL3, IL-6, and TNF-a, a group of
potentially important immunomodulatory genes. It should
be noted that many of the genes selectively upregulated in
KBP over KBM in response to UVB irradiation are also
upregulated in response to CPAF. Yet many genes highly
upregulated in response to CPAF such as IL-8, were not
changed in response to UVB, indicating that the PAF-R role in
UVB-induced gene expression is complex. It should be noted
that the focus of these studies is the role of the early gene
regulation induced by UVB.
TNF-a has important proinflammatory and immunoregu-
latory functions in skin (reviewed by LaDuca and Gaspari,
2001). UVB induces TNF-a in a biphasic manner, with both
early and a later phase (Dazard et al, 2003) with both
upregulation of new mRNA synthesis as well as mRNA
stabilization playing important roles (Leverkus et al., 1998).
Previous microarray studies indicate that the level of TNF-a
upregulation in a carcinoma cell line is approximately five
times greater than in primary cultures of human keratinocytes
(Dazard et al., 2003). The present studies suggest potential
involvement of the PAF system in the early response;
microarray studies cannot distinguish between upregulation
of transcription or mRNA stability.
The role of the chemokine CCL20 in cutaneous function is
not clear. Through its ability to act on the chemokine receptor
CCR6, CCL20 is a potent chemoattractant for immature
dendritic cells and memory/effector T cells (Charbonnier
et al., 1999; Le Borgne et al., 2006). Known stimuli for
keratinocyte CCL20 production include TNF-a, IL-1, allergen,
and irritant exposure (Nakayama et al., 2001; Schmuth et al.,
2002). Of significance, UVB irradiation has been shown to
upregulate CCL20 in both primary cultures of human
keratinocytes as well as in human skin in vivo (Enk et al.,
2006). Given the types of stimuli that generate epidermal
CCL20, it has been suggested that this chemokine serves as
part of the ‘‘alarm system’’ in skin (Spiekstra et al., 2005). Of
note, cellular damage is also a potent stimulus for PAF
production (Alappatt et al., 2000).
In summary, these studies suggest that a rich variety of genes
are regulated by the epidermal PAF-R. Moreover, expression of
the PAF-R can modulate UVB-mediated early gene production,
especially TNF-a and CCL20. These studies provide further
evidence that the PAF system appears to be a target for UVB.
MATERIALS AND METHODS
Reagents
All chemicals were obtained from Sigma (St Louis, MO) unless
indicated otherwise.
Cell culture
The human epithelial cell line KB was grown in DMEM (Life
Technologies Inc., Gaithersburg, MD). Supplemented with 10% fetal
bovine serum (Hyclone, Logan, UT). PAF-R-negative KB cells were
rendered PAF-R-positive (KBP) by transducing the MSCV2.1 retro-
virus encoding the human leukocyte PAF-R as described previously
(Pei et al., 1998) and compared with KB cells transduced with the
vector alone (KBM). KBP and KBM cells were characterized by
KO
WT
NT CPAF UV
KO
WT
NT CPAF UV
Figure 3. Effect of PAF-R agonist on cytokine protein levels in vivo. Skin of wild-type or PAF-R/ mice was injected with BSA vehicle, 100 ng CPAF, or
irradiated with 1,200 J/m2 UVB. After 8 hours, the skin was harvested and subjected to immunohistochemistry to measure (a) TNF-a and (b) CCL20. The above
are representative of findings from four mice of each genotype.
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Southern and Northern blot analysis and by radioligand binding and
calcium mobilization studies to demonstrate that the PAF-R was
functional (Pei et al., 1998; Travers et al., 1998).
UVB irradiation source
Cells and mice were irradiated with UVB as described previously
(Barber et al., 1998). The UV source was a Phillips F20T12/UV-B
lamp (270–390 nm, containing 2.6 UVC, 43.6 UVB, and 53.8%
UVA). The intensity of the UVB source was measured before each
experiment using an IL1700 radiometer and a SED240 UVB detector
(International Light, Newburyport, MA) at a distance of 8 cm from
the UVB source to the monolayer of cells/mice.
Microarray measurements
KBP and KBM cells were treated with 100 nM CPAF or ethanol
(0.1%), vehicle alone, or exposed to 400 J/m2 UVB, and after 1 hour
the RNA was extracted. Four dishes of cells were used for each
treatment, and independently processed and hybridized. Quality of
the RNA was assessed by spectrophotometric scan from 210 to
350 nm and the presence of ribosomal bands and relative lack of
DNA assessed by agarose gels. Biotinylated complementary RNA
was synthesized from the total RNA following the standard protocol
from Affymetrix (GeneChipsExpression Analysis Technical Manual;
Santa Clara, CA, 2001). This included RT using a T7-promoter-dT26
primer followed by cRNA synthesis from the double-stranded
complementary DNA using the ENZO BioArray High Yield RNA
Transcript Labeling Kit (ENZO Diagnostics Inc., Farmingdale, NY).
Fifteen micrograms of fragmented, biotinylated complementary RNA
was mixed into 300ml of hybridization cocktail, of which 200ml was
used for each hybridization. Hybridization was for 17 hours at 421C,
followed by washing, staining, and scanning according to the
standard protocol. Four independent samples were used for each
treatment and hybridized to separate arrays, for a total of 24
Affymetrix Human Genome U133A genechips. Data were extracted
using Affymetrix MicroArray Suite software (MAS5). Probe sets not
reliably detected were excluded from further analysis to reduce false
positives; probe sets had to be ‘‘present’’ in at least three of the four
arrays in at least one of the groups in a comparison (McClintick and
Edenberg, 2006). Comparisons between groups were by t-tests
assuming unequal variance; genes were selected if P-value was
o0.01 and the difference in expression level was at least 2-fold (up
or down). When a gene in the list was measured by more than one
probe set, the set with the highest quality of annotation was
preferentially chosen, then the one with the highest level of present
calls, and then the one with the best P-value.
CCL20 measurements
CCL20 (MIP3a) released protein was measured by ELISA. Briefly,
KBM or KBP cells were plated at 1 106 cells on 10 cm plates for
24 hours, then exposed to media with/without drugs or UVB. In
experiments in which CPAF was used, cells were treated with CPAF
or ethanol vehicle (0.1%). At 6 hours, the supernatants were
removed and tested for CCL20 protein, and cells counted by
automated counter (Coulter, Fullerton, CA).
Murine studies
PAF-R/ mice on a C57BL/6 background were generated as
previously described by Ishii et al. (1998). Age-matched (8–12
weeks) PAF-Rþ /þ C57BL/6 wild-type mice were used as controls.
All mice were housed in a pathogen-free environment, and studies
were approved by the Animal Care and Use Committee of Indiana
University School of Medicine. Intradermal injections of CPAF were
conducted as previously described with minor modifications (Zhang
et al., 2005). In brief, the shaved back skin (approx 2 2 cm) of
anesthetized mice were injected with 50 ml CPAF (100 ng), phorbol
12-myristate 13-acetate (10 mg), or 0.25% fatty acid-free BSA. In
some experiments, the skin was irradiated with 1,200 J/m2 UVB.
After 8 hours, the mice were killed and the involved skin excised,
with half placed in 10% buffered formalin, then paraffin-embedded
and stained with hematoxylin and eosin for routine histology. Half
was snap-frozen in OCT for PCR studies.
RT and quantitative real-time RT-PCR
Frozen tissue was homogenized and total RNA was isolated with
RNeasys mini kit (Qiagen Sciences, Valencia, CA) as described by
the manufacturer. RNA was reverse-transcribed with ReactionRea-
dyTM First-Strand complementary DNA synthesis kit (SuperArray,
Frederick, MD). The quantitative real-time PCR was done with the
TNF-a and CCL20 primer kit (reference positions 628–648 and
447–460, respectively) obtained from SuperArray (Frederick, MD) on
SmartCyclers PCR system with SmartCycler 1.2 software (Cepheid,
Sunnyvale, CA) at 951C for 15min and 40 cycles of (95, 30; 55, 30,
and 721C, 30 seconds) as described by the manufacturer. The
expression levels of TNF-a and CCL20 were normalized to the
expression levels of 18S.
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